A video on reaching a high protein target while keeping calories in check during GLP-1 treatment.
Recap by typeshit. Full story at Countess of Shopping.
2:06:18
A live Q&A from FitFlavorFun taking viewer questions on Zepbound, Ozempic, Wegovy, retatrutide and Korglutide.
People familiar with the matter say the plan under review includes more safeguards for patients than first expected. A policy step worth watching.
Celebrity paparazzi item on Amanda Bynes stepping out in a miniskirt, framed around her reported Ozempic use. Little detail beyond the photos.
The show is collecting experiences from people microdosing GLP-1 drugs, including why they tried it and how they got the medication.
Maqubela's list of 2025 brand revenues puts Ozempic third at $19.2b, ahead of Dupixent and Skyrizi.
Dayan cites 1 in 8 American adults on a GLP-1 and argues the effects reach fashion, food and how patients approach cosmetic care.
Loading…